Is it necessary to improve the intravascular retention of hemoglobin solutions?
D019794:2,3-Diphosphoglycerate; D000818:Animals; D001802:Blood Substitutes / Q000378:metabolism*; D003432:Cross-Linking Reagents; D004163:Diphosphoglyceric Acids / Q000378:metabolism; D004285:Dogs; D006454:Hemoglobins / Q000378:metabolism*; D007700:Kinetics; D008657:Metabolic Clearance Rate; D010100:Oxygen / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000378:metabolism; D051381:Rats; D012771:Shock, Hemorrhagic / Q000628:therapy
D001802:Blood Substitutes; D003432:Cross-Linking Reagents; D004163:Diphosphoglyceric Acids; D006454:Hemoglobins; C016484:hemoglobin, stroma free; D019794:2,3-Diphosphoglycerate; D011732:Pyridoxal Phosphate; D010100:Oxygen